查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1994141

牛健康市場：2026-2032年全球市場預測（依產品類型、牛種、給藥途徑、疾病區域及最終用戶分類）

Cattle Health Market by Product Type, Cattle Type, Mode Of Administration, Disease Area, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，牛健康市場價值將達到 83.3 億美元，到 2026 年將成長到 88.2 億美元，到 2032 年將達到 123.2 億美元，複合年成長率為 5.75%。

主要市場統計數據
基準年 2025 83.3億美元
預計年份：2026年 88.2億美元
預測年份：2032年 123.2億美元
複合年成長率 (%) 5.75%

簡要概述了現代動物管理中重新定義牛健康優先事項、臨床實踐和農場層面決策的因素。

牛健康領域正處於科學進步、監管環境演變和畜牧業經濟轉型交匯的十字路口，迫使生產者和服務提供者重新定義其在動物福利、生產力和生物安全方面的優先事項。在此背景下，價值鏈上的相關人員必須平衡對改善疾病預防和診斷技術的需求，以及日益重視的實際限制因素，例如勞動力供應、供應鏈韌性和合理使用抗生素。本導言概述了後續分析的框架，旨在識別影響產品需求、分銷管道和農場決策的因素。

診斷技術的創新、合理使用抗生素、不斷發展的分銷管道以及精準控制如何重塑產品選擇、臨床管道和農場韌性？

在科學進步、監管重新評估和相關人員期望轉變的推動下，牛的健康格局正在經歷多項變革。診斷技術的快速發展，包括檢查室檢測和攜帶式快速檢測套組，使得細菌性、病毒性和寄生蟲性疾病的早期檢測成為可能，從而支持更有針對性的治療和預防干涉措施。同時，對合理使用抗生素的持續重視正在加速替代治療方法和預防措施的推廣，並推動飼料添加劑組合藥物的發展，這些配方提供酵素、益生元、益生菌、維生素和礦物質，以支持免疫功能和代謝穩定性。

近期關稅措施對與牛健康相關的整個價值鏈的採購、供應連續性和籌資策略的營運和策略影響。

美國近期推出的關稅措施為依賴進口的牛保健供應鏈環節帶來了新的挑戰，導致成本結構和籌資策略發生變化。依賴跨境採購藥品活性成分、診斷試劑、專用疫苗成分和特定飼料添加劑的製造商和經銷商被迫重新評估與供應商的關係，實現貨源多元化，並在某些情況下加快本地化生產，以維持供應的連續性和穩定的利潤率。這些因應措施促使企業重新關注供應鏈圖譜、供應商合格和庫存策略，以減輕關稅衝擊的影響。

這項研究揭示了產品、分銷管道、牛類、疾病、給藥途徑和應用細分如何影響購買行為和創新重點。

細分市場分析揭示了影響購買行為和產品開發重點的微妙需求因素，這些因素涵蓋產品類型、分銷管道、牛類類別、疾病分類、給藥途徑和應用領域。在產品類型內部，診斷產品呈現兩極化的趨勢：檢查室檢測支援確診和監測方案，而快速檢測套組則支援農場和診所的照護現場決策。消毒劑和殺菌劑在生物安全通訊協定嚴格的地區受到優先考慮，而飼料添加劑，包括酵素、益生元、益生菌、維生素和礦物質，則有助於全面提高消化效率和免疫功能。

了解影響產品採用和供應鏈設計的區域性法規結構、生產系統和分銷趨勢的差異。

區域趨勢對牛健康管理的法規結構、疾病流行情況、生產系統和商業策略有顯著影響。在美洲，一體化的商業運營、先進的獸醫基礎設施以及不斷變化的消費者期望，推動了對高效疫苗、精準診斷以及優先考慮合理使用的藥品和飼料添加劑的需求，促使供應商將可追溯性和性能數據作為差異化優勢。在歐洲、中東和非洲，監管的多樣性和生產規模的差異導致產品採用模式的分化。有些市場優先考慮高科技診斷和嚴格的抗​​生素監管，而有些市場則需要經濟高效的配方和完善的低溫運輸物流來應對地方性疾病的壓力。

競爭格局洞察凸顯了綜合產品供應、證據產生和經銷夥伴關係如何定義牛健康市場的領導地位。

牛健康領域的競爭格局呈現出多元化的特徵，既有跨國製藥公司，也有專業動物用藥品公司、診斷技術創新企業和新興飼料添加劑專家。主要企業透過整合疫苗、標靶藥物、診斷技術和技術服務等產品，提供滿足生產者複雜需求的端到端牛健康解決方案，脫穎而出。同時，小規模、更靈活的公司則傾向於專注於細分市場，例如快速照護現場診斷、新型益生菌配方或針對特定區域病原體的在地化疫苗平台。

為製造商和經銷商制定切實可行的策略措施，以增強其韌性，加快部署速度，並改善集團層面的健康結果。

行業領導企業應優先採取一系列措施，以最大限度地利用需求變化帶來的益處，同時降低業務風險。首先，投資診斷能力建設，以支持農場層面的快速決策，並將診斷結果轉化為具體的治療和預防通訊協定。其次，加速採購和生產多元化，以減輕貿易中斷的影響，同時加強供應商選擇標準和庫存策略，以確保供應的連續性。

我們採用透明的混合方法研究途徑，結合相關人員訪談、監管審查和比較分析，為牛的健康提供可操作的見解。

本分析整合了從與行業相關人員的訪談中獲得的定性和定量資訊、對二手文獻的回顧以及對監管和貿易趨勢的比較評估，以確保對牛健康動態形成全面而平衡的觀點。主要研究包括與獸醫、產品經理、分銷主管和農場經營者進行結構化訪談，以收集有關診斷使用模式、治療偏好和採購行為的實地見解。這些直接觀察結果與官方監管文件、疾病管理和藥理學方面的科學文獻以及檢驗的企業資訊披露進行了交叉比對，以提高準確性。

為了推動牛健康管理的永續改進，我們正在整合策略挑戰，並專注於診斷、管理和供應鏈韌性。

總之，牛健康管理領域目前正經歷著建設性的轉型期，診斷技術的進步、管理要求的提高以及分銷管道的創新正在重塑商業性和臨床規範。那些能夠將產品開發、供應鏈韌性以及與獸醫和養殖戶開展循證合作相結合的企業，將更有利於推動技術應用並改善動物福利。區域差異和關稅相關的供應考慮凸顯了製定本地化策略和柔軟性採購對於維持業務連續性和競爭力的重要性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：牛保健市場：依產品類型分類

  • 製藥
    • 抗生素
    • 抗發炎藥和止痛藥
    • 荷爾蒙和生殖療法
    • 胃腸道治療
    • 呼吸治療
  • 疫苗
    • 減毒活病毒疫苗
    • 去活化疫苗
    • 類毒素疫苗
    • 重組疫苗和次單位疫苗
    • 聯合疫苗
  • 殺蟲劑
    • 體外寄生蟲控制劑
    • 體內寄生蟲控制劑
    • 體內外寄生蟲控制劑
  • 診斷
    • 農場快速檢測
    • 實驗室檢測
    • 進階影像診斷
    • 數位監控工具
  • 營養產品
    • 礦物質補充劑
    • 維生素補充劑
    • 益生菌和益生元
    • 電解質和補水產品
    • 特殊治療飼料
  • 飼料添加劑
    • 提高生產效率的添加劑
    • 黴菌毒素吸附劑
    • 酵素添加劑
    • 酸味劑和緩衝劑
  • 監測設備和穿戴式裝置
    • 衣領和頸標
    • 耳標植入
    • 反芻和攝食感測器
    • 活動和運動感測器
    • 健康事件警報系統
  • 農場管理軟體服務
    • 健康記錄管理
    • 決策支援/分析
    • 遠端醫療和遠距監測平台
    • 整合資訊服務

第9章：牛健康市場：以牛的類型分類

  • 牛
  • 牛
  • 雙用途牛
  • 牛
  • 種牛和種牛

第10章：牛健康市場：依給藥途徑分類

  • 口服
    • Bolus/片劑
    • 口服
    • 糊狀凝膠
    • 藥用飼料
  • 注射藥物
    • 皮下注射
    • 肌肉內注射
    • 靜脈注射
  • 外用
    • 毛孔細緻滴劑
    • 噴塗浸漬
    • 藥膏和乳霜
  • 在乳房
    • 泌乳牛的乳房內給藥
    • 乾乳牛的子宮內給藥
  • 鼻內
  • 嵌入式
    • 生長激素植入
    • 長效藥物植入
  • 飼料添加劑型
  • 水溶性

第11章牛健康市場：依疾病區域分類

  • 感染疾病
    • 細菌感染疾病
    • 病毒感染疾病
    • 黴菌感染疾病
    • 混合感染疾病和性行為感染
  • 寄生蟲病
    • 體內寄生蟲
    • 體外寄生蟲
    • 原蟲性疾病
  • 乳腺炎和乳房健康
  • 呼吸系統疾病
    • 上呼吸道疾病
    • 下呼吸道疾病
    • 複雜呼吸症候群
  • 消化系統疾病
    • 腹瀉疾病
    • 腹瀉和酸中毒
  • 代謝和營養紊亂
    • 能量代謝紊亂
    • 礦物質失衡
    • 維生素缺乏
    • 管腔功能障礙
  • 生殖和產科疾病
    • 育種管理問題
    • 分娩前、分娩中、分娩後的疾病
    • 性行為感染傳染病
  • 跛行和肌肉骨骼疾病
    • 蹄甲疾病
    • 關節和肢體疾病
    • 創傷/損傷

第12章牛健康市場：依最終用戶分類

  • 大型商業農場
  • 中小農場
  • 獸醫醫院和診所
  • 移動式和現場獸醫服務
  • 畜牧合作社和生產者組織
  • 政府和學術機構
  • 動物健康服務提供者
    • 育種管理服務供應商
    • 牛健康諮詢公司
    • 外部聯絡及諮詢服務

第13章牛健康市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章牛健康市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章牛健康市場：按國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國牛健康市場

第17章：中國牛健康市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Biomin GmbH
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale SA
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Hester Biosciences Limited
  • Huvepharma AD
  • IDEXX Laboratories, Inc.
  • Indian Immunologicals Limited
  • Intas Pharmaceuticals Ltd.
  • Jurox Pty Ltd.
  • Kemin Industries, Inc.
  • Laboratorios Hipra, SA
  • Meiji Seika Pharma Co., Ltd.
  • Merck & Co., Inc.
  • Neogen Corporation
  • Norbrook Laboratories Ltd.
  • Ouro Fino Saude Animal Ltda.
  • Phibro Animal Health Corporation
  • PhytobIoTics Futterzusatzstoffe GmbH
  • Vaxxinova International BV
  • Vetoquinol SA
  • Virbac SA
  • Zoetis Inc.
  • Zydus Animal Health and Investments Limited
Product Code: MRR-1A1A064C0406

The Cattle Health Market was valued at USD 8.33 billion in 2025 and is projected to grow to USD 8.82 billion in 2026, with a CAGR of 5.75%, reaching USD 12.32 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 8.33 billion
Estimated Year [2026] USD 8.82 billion
Forecast Year [2032] USD 12.32 billion
CAGR (%) 5.75%

A concise contextual overview of the forces redefining cattle health priorities, clinical practice, and farm-level decision-making in modern animal management

The cattle health landscape is at a crossroads where scientific progress, regulatory evolution, and shifting farm economics are converging to redefine how producers and service providers prioritize animal welfare, productivity, and biosecurity. In this context, stakeholders across the value chain must reconcile the push for improved disease prevention and diagnostics with practical constraints such as labor availability, supply chain resilience, and rising emphasis on antimicrobial stewardship. This introduction frames the subsequent analysis by clarifying the forces shaping product demand, influencing distribution choices, and altering farm-level decision-making.

This report centers on the tangible intersections between innovation and implementation: how laboratory and point-of-care diagnostics are altering clinical workflows; how feed additives and targeted pharmaceuticals are being integrated into herd health plans; and how vaccines, both established and emerging, are being deployed to mitigate infectious and parasitic challenges. By establishing this baseline, readers will gain a clear understanding of why certain intervention categories are gaining prominence and how institutional and farm-level priorities are adapting in response to animal health imperatives and market pressures.

Throughout the ensuing sections, we connect strategic implications to operational realities, helping executives, product managers, and veterinarians align R&D, commercial planning, and on-the-ground practices to improve cattle health outcomes while managing cost and compliance considerations.

How diagnostic innovation, antimicrobial stewardship, distribution evolution, and precision management are reshaping product selection, clinical pathways, and farm resilience

The landscape of cattle health is experiencing several transformative shifts driven by scientific advances, regulatory recalibration, and changing stakeholder expectations. Rapid improvements in diagnostics technology, including laboratory testing and portable rapid test kits, are enabling earlier detection of bacterial, viral, and parasitic conditions, which in turn supports more targeted therapeutic and preventive interventions. Simultaneously, continued emphasis on antimicrobial stewardship is accelerating adoption of alternative therapeutics and preventive measures, incentivizing growth in feed additive formulations that deliver enzymes, prebiotics, probiotics, vitamins, and minerals to support immunity and metabolic stability.

Distribution models are evolving as well, with online channels complementing traditional farm supply outlets, pharmacies, and veterinary hospitals to improve accessibility and traceability of products. Regulatory scrutiny around hormones and growth promoters, coupled with heightened consumer interest in sustainable and welfare-oriented production, is prompting manufacturers to diversify portfolios toward vaccines and non-antibiotic therapeutic options. In parallel, data-driven herd management and precision livestock farming techniques are informing product selection and administration routes, with injectable, oral, topical, and inhalation options being deployed in more strategic and condition-specific ways.

Taken together, these shifts signal a move from broad, reactive interventions toward integrated, preventive, and data-informed strategies that prioritize herd resilience, product safety, and long-term viability for producers and value chain partners.

Operational and strategic consequences of recent tariff measures on sourcing, supply continuity, and procurement strategies across the cattle health value chain

Recent tariff actions in the United States introduced new considerations for import-dependent segments of the cattle health supply chain, altering cost structures and procurement strategies. Manufacturers and distributors that rely on cross-border sourcing for active pharmaceutical ingredients, diagnostic reagents, specialized vaccine components, and certain feed additive raw materials have had to reassess supplier relationships, diversify sourcing footprints, and, in some instances, accelerate localization of production to maintain supply continuity and margin stability. These operational responses have translated into renewed emphasis on supply chain mapping, vendor qualification, and inventory strategies to reduce exposure to tariff-driven disruptions.

At the same time, regulatory agencies and trade partners are adapting to the changed trade environment through procedural clarifications and bilateral dialogues intended to minimize unintended consequences for animal health inputs. The net effect for industry participants is a heightened need for commercial agility: procurement teams are pursuing multi-sourcing and strategic stockholding while product managers are evaluating reformulation opportunities that reduce reliance on tariff-sensitive inputs. Veterinary service providers and farm operators are also adjusting purchasing cadence and product selection, preferring accessible distribution channels that mitigate delivery risks.

In short, tariffs have reinforced the strategic importance of resilient value chains, compelling companies across the cattle health ecosystem to invest in sourcing flexibility, supplier partnerships, and near-term operational contingency planning to safeguard animal care and business continuity.

Clarifying how product, channel, cattle category, disease, administration route, and application segmentation combine to direct purchasing behavior and innovation priorities

Segmentation analysis reveals nuanced demand drivers across product types, distribution channels, cattle categories, disease classes, administration routes, and applications, each shaping purchasing behavior and product development priorities. Within product categories, diagnostics present a bifurcated landscape where laboratory testing supports confirmatory and surveillance programs while rapid test kits enable point-of-care decision-making on farms and in clinics. Disinfectants and sanitizers are prioritized where biosecurity protocols are stringent, and feed additives span enzymes, prebiotics and probiotics, plus vitamins and minerals that collectively address digestive efficiency and immune competence.

Pharmaceutical portfolios require careful segmentation: anthelmintics remain essential for parasite control, anti-inflammatories address acute clinical needs, antibiotics are increasingly subject to stewardship constraints, and hormones and growth promoters face regulatory and market scrutiny that influence adoption. Vaccines span bacterial, parasitic, and viral targets and are central to preventive herd health strategies. Distribution patterns show that farm supplies outlets continue to be primary procurement points for routine products, while online channels are expanding accessibility and transactional efficiency; pharmacies and veterinary hospitals and clinics play critical roles for prescription and professionally administered interventions.

Cattle types-beef, calves, and dairy-exhibit distinct health management priorities linked to production cycles, nutrition, and disease susceptibility, driving divergent demand for formulation types and administration routes. Disease-type segmentation underscores the breadth of clinical focus areas, from bacterial and viral infections to parasitic and metabolic disorders and reproductive and respiratory conditions, each requiring tailored diagnostic, preventive, and therapeutic approaches. Administration routes-injectable, oral, topical, and inhalation-must align with product pharmacokinetics, ease of use on farm, and welfare considerations. Finally, applications ranging from growth promotion and nutritional supplementation to preventive, reproductive management, and therapeutic uses determine how products are positioned commercially and integrated into herd health programs.

Understanding regional variation in regulatory frameworks, production systems, and distribution dynamics that shape product adoption and supply chain design

Regional dynamics exert a strong influence on regulatory frameworks, disease prevalence, production systems, and commercial strategies in cattle health. In the Americas, integrated commercial operations, advanced veterinary infrastructure, and evolving consumer expectations drive demand for high-efficacy vaccines, precision diagnostics, and stewardship-aligned pharmaceuticals and feed additives, prompting suppliers to emphasize traceability and performance data as differentiators. Across Europe, the Middle East and Africa, regulatory diversity and varied production scales mean that product adoption patterns diverge: some markets prioritize high-tech diagnostics and stringent antibiotic regulations, while others require cost-sensitive formulations and robust cold-chain logistics to manage endemic disease pressures.

Asia-Pacific presents distinct dynamics with rapid modernization of dairy and beef systems, heterogeneous disease burdens, and expanding distribution ecosystems where online channels and veterinary clinics are increasingly influential. Regional procurement and supply chain approaches reflect these conditions: manufacturers adapt packaging, formulations, and support services for diverse cold-chain capabilities, veterinary capacity, and farm management practices. Moreover, public and private sector disease control programs and regional trade policies shape vaccine deployment strategies and prioritize interventions that address prevalent bacterial, viral, and parasitic challenges.

Understanding these regional nuances enables companies to align product development, registration strategies, and commercial engagement to the specific needs of producers, veterinarians, and regulators in each geography, thereby improving adoption and impact.

Competitive landscape insights highlighting how integrated product offerings, evidence generation, and distribution partnerships define leadership in cattle health markets

Competitive dynamics in the cattle health space reflect a mix of multinational pharmaceutical firms, specialized animal health companies, diagnostic innovators, and emerging feed additive specialists. Leading players differentiate through integrated offerings that combine vaccines, targeted pharmaceuticals, diagnostics, and technical services, enabling end-to-end herd health solutions that resonate with progressive producers. Meanwhile, smaller, agile firms often focus on niche opportunities such as rapid point-of-care diagnostics, novel probiotic blends, or localized vaccine platforms that address region-specific pathogens.

Collaboration between manufacturers and veterinary services is a growing strategic priority, with companies investing in field trials, real-world evidence generation, and educational programs to demonstrate product value and encourage protocol adoption. Strategic partnerships with distribution networks, including online platforms and veterinary hospitals, are expanding reach and streamlining procurement, while investments in cold-chain logistics and regulatory affairs capabilities help accelerate market entry and maintain product integrity. Additionally, companies are increasingly transparent about stewardship commitments and data transparency, which strengthens trust with veterinarians, producers, and regulators.

Going forward, competitive advantage will accrue to organizations that combine technical innovation with robust supply chain safeguards, evidence-based engagement, and services that lower adoption friction for farm operators and clinical practitioners.

Practical, high-impact strategic moves for manufacturers and distributors to strengthen resilience, accelerate adoption, and improve herd-level health outcomes

Industry leaders should pursue a set of prioritized actions to capitalize on evolving demand while reducing operational risk. First, invest in diagnostic capabilities that support rapid, on-farm decision-making and link diagnostic outputs to actionable treatment and prevention protocols. Second, accelerate diversification of sourcing and production to reduce exposure to trade-related disruptions, while strengthening supplier qualification and inventory strategies to maintain continuity of supply.

Third, reframe product portfolios to emphasize antimicrobial stewardship and non-antibiotic interventions, pairing therapeutics with vaccination strategies and targeted feed additives that support immune resilience and metabolic health. Fourth, deepen engagement with distribution partners across farm supply outlets, online channels, pharmacies, and veterinary hospitals to enhance accessibility and ensure appropriate product use. Fifth, tailor regional go-to-market approaches that reflect the distinct regulatory, logistical, and disease prevalence conditions in the Americas, Europe Middle East & Africa, and Asia-Pacific, and invest in localized trials and educational outreach to support adoption.

Finally, augment competitive positioning by generating robust field data, leveraging digital tools for herd-level insights, and offering service-oriented solutions that simplify adoption. Taken together, these steps will enable companies to deliver higher value, mitigate operational risk, and align product strategy with the practical needs of veterinarians and producers.

Transparent mixed-methods research approach combining stakeholder interviews, regulatory review, and comparative analysis to support actionable cattle health insights

This analysis synthesizes qualitative and quantitative inputs drawn from primary interviews with industry stakeholders, secondary literature review, and comparative assessment of regulatory and trade developments to ensure a comprehensive and balanced perspective on cattle health dynamics. Primary research included structured conversations with veterinary practitioners, product managers, distribution executives, and farm operators to capture on-the-ground insights into diagnostic use patterns, treatment preferences, and procurement behaviors. These firsthand observations were triangulated with public regulatory documentation, scientific literature on disease management and pharmacology, and validated company disclosures to enhance accuracy.

The methodology emphasizes transparency and replicability: sources were documented, thematic coding was applied to interview data, and cross-validation checks were conducted to reconcile divergent viewpoints. Where appropriate, scenario analysis was used to assess operational responses to trade and supply chain disruptions, while technology and adoption trends were evaluated through product pipeline reviews and stakeholder readiness assessments. This mixed-methods approach ensures the findings reflect both technical realities and commercial practicalities relevant to decision-makers across the cattle health ecosystem.

Synthesis of strategic imperatives emphasizing diagnostics, stewardship, and supply chain resilience to guide sustainable improvements in cattle health management

In conclusion, the cattle health sector is navigating a period of constructive disruption where diagnostic advances, stewardship imperatives, and distribution innovations are reshaping commercial and clinical norms. Companies that align product development, supply chain resilience, and evidence-based engagement with veterinarians and producers will be better positioned to influence adoption and improve animal welfare outcomes. Regional heterogeneity and tariff-induced supply considerations underscore the importance of tailored strategies and sourcing flexibility to maintain continuity and competitiveness.

The practical implications for stakeholders are clear: prioritize diagnostics and preventive measures that reduce reliance on broad-spectrum therapeutics, invest in formulation and logistics that suit local production systems, and cultivate partnerships that bring clinical credibility and distribution efficiency. By translating these insights into coordinated action-spanning R&D prioritization, supplier diversification, and targeted market engagement-industry participants can address immediate operational challenges while building sustainable pathways for long-term improvement in cattle health.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cattle Health Market, by Product Type

  • 8.1. Pharmaceuticals
    • 8.1.1. Antibiotics
    • 8.1.2. Anti-inflammatory & Analgesics
    • 8.1.3. Hormones & Reproductive Therapies
    • 8.1.4. Gastrointestinal Therapies
    • 8.1.5. Respiratory Therapies
  • 8.2. Vaccines
    • 8.2.1. Live Attenuated Vaccines
    • 8.2.2. Inactivated Vaccines
    • 8.2.3. Toxoid Vaccines
    • 8.2.4. Recombinant & Subunit Vaccines
    • 8.2.5. Combination Vaccines
  • 8.3. Parasiticides
    • 8.3.1. Ectoparasiticides
    • 8.3.2. Endoparasiticides
    • 8.3.3. Endectocides
  • 8.4. Diagnostics
    • 8.4.1. Rapid On-farm Tests
    • 8.4.2. Laboratory-based Tests
    • 8.4.3. Imaging & Advanced Diagnostics
    • 8.4.4. Digital Monitoring Tools
  • 8.5. Nutritional Products
    • 8.5.1. Mineral Supplements
    • 8.5.2. Vitamin Supplements
    • 8.5.3. Probiotics & Prebiotics
    • 8.5.4. Electrolytes & Rehydration Products
    • 8.5.5. Specialized Therapeutic Diets
  • 8.6. Feed Additives
    • 8.6.1. Performance-enhancing Additives
    • 8.6.2. Mycotoxin Binders
    • 8.6.3. Enzyme Additives
    • 8.6.4. Acidifiers & Buffers
  • 8.7. Monitoring Devices & Wearables
    • 8.7.1. Collars & Neck Tags
    • 8.7.2. Ear Tags & Implants
    • 8.7.3. Rumination & Ingestion Sensors
    • 8.7.4. Activity & Locomotion Sensors
    • 8.7.5. Health Event Alert Systems
  • 8.8. Farm Management Software & Services
    • 8.8.1. Health Record Management
    • 8.8.2. Decision Support & Analytics
    • 8.8.3. Telemedicine & Remote Monitoring Platforms
    • 8.8.4. Integration & Data Services

9. Cattle Health Market, by Cattle Type

  • 9.1. Dairy Cattle
  • 9.2. Beef Cattle
  • 9.3. Dual-purpose Cattle
  • 9.4. Calves
  • 9.5. Bulls & Breeding Stock

10. Cattle Health Market, by Mode Of Administration

  • 10.1. Oral
    • 10.1.1. Boluses & Tablets
    • 10.1.2. Drenches
    • 10.1.3. Pastes & Gels
    • 10.1.4. Medicated Feeds
  • 10.2. Injectable
    • 10.2.1. Subcutaneous Injections
    • 10.2.2. Intramuscular Injections
    • 10.2.3. Intravenous Injections
  • 10.3. Topical
    • 10.3.1. Pour-ons & Spot-ons
    • 10.3.2. Sprays & Dips
    • 10.3.3. Ointments & Creams
  • 10.4. Intramammary
    • 10.4.1. Lactating Cow Intramammary
    • 10.4.2. Dry Cow Intramammary
  • 10.5. Intranasal
  • 10.6. Implantable
    • 10.6.1. Growth & Hormonal Implants
    • 10.6.2. Long-acting Drug Implants
  • 10.7. Feed-based
  • 10.8. Water-based

11. Cattle Health Market, by Disease Area

  • 11.1. Infectious Diseases
    • 11.1.1. Bacterial Infections
    • 11.1.2. Viral Infections
    • 11.1.3. Fungal Infections
    • 11.1.4. Mixed & Opportunistic Infections
  • 11.2. Parasitic Diseases
    • 11.2.1. Internal Parasites
    • 11.2.2. External Parasites
    • 11.2.3. Protozoal Infections
  • 11.3. Mastitis & Udder Health
  • 11.4. Respiratory Diseases
    • 11.4.1. Upper Respiratory Diseases
    • 11.4.2. Lower Respiratory Diseases
    • 11.4.3. Complex Respiratory Syndromes
  • 11.5. Gastrointestinal Diseases
    • 11.5.1. Diarrheal Diseases
    • 11.5.2. Bloat & Acidosis
  • 11.6. Metabolic & Nutritional Disorders
    • 11.6.1. Energy Metabolism Disorders
    • 11.6.2. Mineral Imbalances
    • 11.6.3. Vitamin Deficiencies
    • 11.6.4. Rumen Function Disorders
  • 11.7. Reproductive & Obstetric Disorders
    • 11.7.1. Fertility Management Issues
    • 11.7.2. Peripartum & Postpartum Disorders
    • 11.7.3. Venereal Diseases
  • 11.8. Lameness & Musculoskeletal Disorders
    • 11.8.1. Hoof & Claw Disorders
    • 11.8.2. Joint & Limb Disorders
    • 11.8.3. Trauma & Injury

12. Cattle Health Market, by End User

  • 12.1. Large Commercial Farms
  • 12.2. Small & Medium Farms
  • 12.3. Veterinary Hospitals & Clinics
  • 12.4. Mobile & Ambulatory Veterinary Services
  • 12.5. Livestock Cooperatives & Producer Groups
  • 12.6. Government & Academic Institutions
  • 12.7. Animal Health Service Providers
    • 12.7.1. Reproductive Management Service Providers
    • 12.7.2. Herd Health Consulting Firms
    • 12.7.3. Extension & Advisory Services

13. Cattle Health Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Cattle Health Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Cattle Health Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Cattle Health Market

17. China Cattle Health Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Biomin GmbH
  • 18.6. Boehringer Ingelheim International GmbH
  • 18.7. Ceva Sante Animale SA
  • 18.8. Dechra Pharmaceuticals PLC
  • 18.9. Elanco Animal Health Incorporated
  • 18.10. Hester Biosciences Limited
  • 18.11. Huvepharma AD
  • 18.12. IDEXX Laboratories, Inc.
  • 18.13. Indian Immunologicals Limited
  • 18.14. Intas Pharmaceuticals Ltd.
  • 18.15. Jurox Pty Ltd.
  • 18.16. Kemin Industries, Inc.
  • 18.17. Laboratorios Hipra, S.A.
  • 18.18. Meiji Seika Pharma Co., Ltd.
  • 18.19. Merck & Co., Inc.
  • 18.20. Neogen Corporation
  • 18.21. Norbrook Laboratories Ltd.
  • 18.22. Ouro Fino Saude Animal Ltda.
  • 18.23. Phibro Animal Health Corporation
  • 18.24. Phytobiotics Futterzusatzstoffe GmbH
  • 18.25. Vaxxinova International B.V.
  • 18.26. Vetoquinol SA
  • 18.27. Virbac SA
  • 18.28. Zoetis Inc.
  • 18.29. Zydus Animal Health and Investments Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL CATTLE HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CATTLE HEALTH MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CATTLE HEALTH MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CATTLE HEALTH MARKET SIZE, BY MODE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CATTLE HEALTH MARKET SIZE, BY DISEASE AREA, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CATTLE HEALTH MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CATTLE HEALTH MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CATTLE HEALTH MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES CATTLE HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA CATTLE HEALTH MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CATTLE HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTI-INFLAMMATORY & ANALGESICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTI-INFLAMMATORY & ANALGESICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTI-INFLAMMATORY & ANALGESICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CATTLE HEALTH MARKET SIZE, BY HORMONES & REPRODUCTIVE THERAPIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CATTLE HEALTH MARKET SIZE, BY HORMONES & REPRODUCTIVE THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CATTLE HEALTH MARKET SIZE, BY HORMONES & REPRODUCTIVE THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CATTLE HEALTH MARKET SIZE, BY GASTROINTESTINAL THERAPIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CATTLE HEALTH MARKET SIZE, BY GASTROINTESTINAL THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CATTLE HEALTH MARKET SIZE, BY GASTROINTESTINAL THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CATTLE HEALTH MARKET SIZE, BY RESPIRATORY THERAPIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CATTLE HEALTH MARKET SIZE, BY RESPIRATORY THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CATTLE HEALTH MARKET SIZE, BY RESPIRATORY THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CATTLE HEALTH MARKET SIZE, BY VACCINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CATTLE HEALTH MARKET SIZE, BY VACCINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CATTLE HEALTH MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CATTLE HEALTH MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CATTLE HEALTH MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CATTLE HEALTH MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CATTLE HEALTH MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CATTLE HEALTH MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CATTLE HEALTH MARKET SIZE, BY INACTIVATED VACCINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CATTLE HEALTH MARKET SIZE, BY INACTIVATED VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CATTLE HEALTH MARKET SIZE, BY TOXOID VACCINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CATTLE HEALTH MARKET SIZE, BY TOXOID VACCINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CATTLE HEALTH MARKET SIZE, BY TOXOID VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CATTLE HEALTH MARKET SIZE, BY RECOMBINANT & SUBUNIT VACCINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CATTLE HEALTH MARKET SIZE, BY RECOMBINANT & SUBUNIT VACCINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CATTLE HEALTH MARKET SIZE, BY RECOMBINANT & SUBUNIT VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CATTLE HEALTH MARKET SIZE, BY COMBINATION VACCINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CATTLE HEALTH MARKET SIZE, BY COMBINATION VACCINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CATTLE HEALTH MARKET SIZE, BY COMBINATION VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CATTLE HEALTH MARKET SIZE, BY PARASITICIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CATTLE HEALTH MARKET SIZE, BY PARASITICIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CATTLE HEALTH MARKET SIZE, BY PARASITICIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CATTLE HEALTH MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CATTLE HEALTH MARKET SIZE, BY ECTOPARASITICIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CATTLE HEALTH MARKET SIZE, BY ECTOPARASITICIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CATTLE HEALTH MARKET SIZE, BY ECTOPARASITICIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CATTLE HEALTH MARKET SIZE, BY ENDOPARASITICIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CATTLE HEALTH MARKET SIZE, BY ENDOPARASITICIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CATTLE HEALTH MARKET SIZE, BY ENDOPARASITICIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CATTLE HEALTH MARKET SIZE, BY ENDECTOCIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CATTLE HEALTH MARKET SIZE, BY ENDECTOCIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CATTLE HEALTH MARKET SIZE, BY ENDECTOCIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CATTLE HEALTH MARKET SIZE, BY RAPID ON-FARM TESTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CATTLE HEALTH MARKET SIZE, BY RAPID ON-FARM TESTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CATTLE HEALTH MARKET SIZE, BY RAPID ON-FARM TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CATTLE HEALTH MARKET SIZE, BY LABORATORY-BASED TESTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CATTLE HEALTH MARKET SIZE, BY LABORATORY-BASED TESTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CATTLE HEALTH MARKET SIZE, BY LABORATORY-BASED TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CATTLE HEALTH MARKET SIZE, BY IMAGING & ADVANCED DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CATTLE HEALTH MARKET SIZE, BY IMAGING & ADVANCED DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CATTLE HEALTH MARKET SIZE, BY IMAGING & ADVANCED DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CATTLE HEALTH MARKET SIZE, BY DIGITAL MONITORING TOOLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CATTLE HEALTH MARKET SIZE, BY DIGITAL MONITORING TOOLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CATTLE HEALTH MARKET SIZE, BY DIGITAL MONITORING TOOLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CATTLE HEALTH MARKET SIZE, BY NUTRITIONAL PRODUCTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CATTLE HEALTH MARKET SIZE, BY NUTRITIONAL PRODUCTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CATTLE HEALTH MARKET SIZE, BY NUTRITIONAL PRODUCTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CATTLE HEALTH MARKET SIZE, BY NUTRITIONAL PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CATTLE HEALTH MARKET SIZE, BY MINERAL SUPPLEMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CATTLE HEALTH MARKET SIZE, BY MINERAL SUPPLEMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CATTLE HEALTH MARKET SIZE, BY MINERAL SUPPLEMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CATTLE HEALTH MARKET SIZE, BY VITAMIN SUPPLEMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CATTLE HEALTH MARKET SIZE, BY VITAMIN SUPPLEMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CATTLE HEALTH MARKET SIZE, BY VITAMIN SUPPLEMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CATTLE HEALTH MARKET SIZE, BY PROBIOTICS & PREBIOTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CATTLE HEALTH MARKET SIZE, BY PROBIOTICS & PREBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CATTLE HEALTH MARKET SIZE, BY PROBIOTICS & PREBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL CATTLE HEALTH MARKET SIZE, BY ELECTROLYTES & REHYDRATION PRODUCTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CATTLE HEALTH MARKET SIZE, BY ELECTROLYTES & REHYDRATION PRODUCTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL CATTLE HEALTH MARKET SIZE, BY ELECTROLYTES & REHYDRATION PRODUCTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL CATTLE HEALTH MARKET SIZE, BY SPECIALIZED THERAPEUTIC DIETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL CATTLE HEALTH MARKET SIZE, BY SPECIALIZED THERAPEUTIC DIETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL CATTLE HEALTH MARKET SIZE, BY SPECIALIZED THERAPEUTIC DIETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL CATTLE HEALTH MARKET SIZE, BY PERFORMANCE-ENHANCING ADDITIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL CATTLE HEALTH MARKET SIZE, BY PERFORMANCE-ENHANCING ADDITIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL CATTLE HEALTH MARKET SIZE, BY PERFORMANCE-ENHANCING ADDITIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL CATTLE HEALTH MARKET SIZE, BY MYCOTOXIN BINDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL CATTLE HEALTH MARKET SIZE, BY MYCOTOXIN BINDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL CATTLE HEALTH MARKET SIZE, BY MYCOTOXIN BINDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL CATTLE HEALTH MARKET SIZE, BY ENZYME ADDITIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL CATTLE HEALTH MARKET SIZE, BY ENZYME ADDITIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL CATTLE HEALTH MARKET SIZE, BY ENZYME ADDITIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL CATTLE HEALTH MARKET SIZE, BY ACIDIFIERS & BUFFERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL CATTLE HEALTH MARKET SIZE, BY ACIDIFIERS & BUFFERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL CATTLE HEALTH MARKET SIZE, BY ACIDIFIERS & BUFFERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL CATTLE HEALTH MARKET SIZE, BY MONITORING DEVICES & WEARABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL CATTLE HEALTH MARKET SIZE, BY MONITORING DEVICES & WEARABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL CATTLE HEALTH MARKET SIZE, BY MONITORING DEVICES & WEARABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL CATTLE HEALTH MARKET SIZE, BY MONITORING DEVICES & WEARABLES, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL CATTLE HEALTH MARKET SIZE, BY COLLARS & NECK TAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL CATTLE HEALTH MARKET SIZE, BY COLLARS & NECK TAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL CATTLE HEALTH MARKET SIZE, BY COLLARS & NECK TAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL CATTLE HEALTH MARKET SIZE, BY EAR TAGS & IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL CATTLE HEALTH MARKET SIZE, BY EAR TAGS & IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL CATTLE HEALTH MARKET SIZE, BY EAR TAGS & IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL CATTLE HEALTH MARKET SIZE, BY RUMINATION & INGESTION SENSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL CATTLE HEALTH MARKET SIZE, BY RUMINATION & INGESTION SENSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL CATTLE HEALTH MARKET SIZE, BY RUMINATION & INGESTION SENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL CATTLE HEALTH MARKET SIZE, BY ACTIVITY & LOCOMOTION SENSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL CATTLE HEALTH MARKET SIZE, BY ACTIVITY & LOCOMOTION SENSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL CATTLE HEALTH MARKET SIZE, BY ACTIVITY & LOCOMOTION SENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL CATTLE HEALTH MARKET SIZE, BY HEALTH EVENT ALERT SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL CATTLE HEALTH MARKET SIZE, BY HEALTH EVENT ALERT SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL CATTLE HEALTH MARKET SIZE, BY HEALTH EVENT ALERT SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL CATTLE HEALTH MARKET SIZE, BY FARM MANAGEMENT SOFTWARE & SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL CATTLE HEALTH MARKET SIZE, BY FARM MANAGEMENT SOFTWARE & SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL CATTLE HEALTH MARKET SIZE, BY FARM MANAGEMENT SOFTWARE & SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL CATTLE HEALTH MARKET SIZE, BY FARM MANAGEMENT SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL CATTLE HEALTH MARKET SIZE, BY HEALTH RECORD MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL CATTLE HEALTH MARKET SIZE, BY HEALTH RECORD MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL CATTLE HEALTH MARKET SIZE, BY HEALTH RECORD MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL CATTLE HEALTH MARKET SIZE, BY DECISION SUPPORT & ANALYTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL CATTLE HEALTH MARKET SIZE, BY DECISION SUPPORT & ANALYTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL CATTLE HEALTH MARKET SIZE, BY DECISION SUPPORT & ANALYTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL CATTLE HEALTH MARKET SIZE, BY TELEMEDICINE & REMOTE MONITORING PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL CATTLE HEALTH MARKET SIZE, BY TELEMEDICINE & REMOTE MONITORING PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL CATTLE HEALTH MARKET SIZE, BY TELEMEDICINE & REMOTE MONITORING PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL CATTLE HEALTH MARKET SIZE, BY INTEGRATION & DATA SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL CATTLE HEALTH MARKET SIZE, BY INTEGRATION & DATA SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL CATTLE HEALTH MARKET SIZE, BY INTEGRATION & DATA SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL CATTLE HEALTH MARKET SIZE, BY DAIRY CATTLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL CATTLE HEALTH MARKET SIZE, BY DAIRY CATTLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL CATTLE HEALTH MARKET SIZE, BY DAIRY CATTLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL CATTLE HEALTH MARKET SIZE, BY BEEF CATTLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL CATTLE HEALTH MARKET SIZE, BY BEEF CATTLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL CATTLE HEALTH MARKET SIZE, BY BEEF CATTLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL CATTLE HEALTH MARKET SIZE, BY DUAL-PURPOSE CATTLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL CATTLE HEALTH MARKET SIZE, BY DUAL-PURPOSE CATTLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL CATTLE HEALTH MARKET SIZE, BY DUAL-PURPOSE CATTLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL CATTLE HEALTH MARKET SIZE, BY CALVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL CATTLE HEALTH MARKET SIZE, BY CALVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL CATTLE HEALTH MARKET SIZE, BY CALVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL CATTLE HEALTH MARKET SIZE, BY BULLS & BREEDING STOCK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL CATTLE HEALTH MARKET SIZE, BY BULLS & BREEDING STOCK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL CATTLE HEALTH MARKET SIZE, BY BULLS & BREEDING STOCK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL CATTLE HEALTH MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL CATTLE HEALTH MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL CATTLE HEALTH MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL CATTLE HEALTH MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL CATTLE HEALTH MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL CATTLE HEALTH MARKET SIZE, BY BOLUSES & TABLETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL CATTLE HEALTH MARKET SIZE, BY BOLUSES & TABLETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL CATTLE HEALTH MARKET SIZE, BY BOLUSES & TABLETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL CATTLE HEALTH MARKET SIZE, BY DRENCHES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL CATTLE HEALTH MARKET SIZE, BY DRENCHES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL CATTLE HEALTH MARKET SIZE, BY DRENCHES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL CATTLE HEALTH MARKET SIZE, BY PASTES & GELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL CATTLE HEALTH MARKET SIZE, BY PASTES & GELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL CATTLE HEALTH MARKET SIZE, BY PASTES & GELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL CATTLE HEALTH MARKET SIZE, BY MEDICATED FEEDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL CATTLE HEALTH MARKET SIZE, BY MEDICATED FEEDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL CATTLE HEALTH MARKET SIZE, BY MEDICATED FEEDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL CATTLE HEALTH MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL CATTLE HEALTH MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL CATTLE HEALTH MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL CATTLE HEALTH MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL CATTLE HEALTH MARKET SIZE, BY SUBCUTANEOUS INJECTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL CATTLE HEALTH MARKET SIZE, BY SUBCUTANEOUS INJECTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL CATTLE HEALTH MARKET SIZE, BY SUBCUTANEOUS INJECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL CATTLE HEALTH MARKET SIZE, BY INTRAMUSCULAR INJECTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 181. GLOBAL CATTLE HEALTH MARKET SIZE, BY INTRAMUSCULAR INJECTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL CATTLE HEALTH MARKET SIZE, BY INTRAMUSCULAR INJECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL CATTLE HEALTH MARKET SIZE, BY INTRAVENOUS INJECTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 184. GLOBAL CATTLE HEALTH MARKET SIZE, BY INTRAVENOUS INJECTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL CATTLE HEALTH MARKET SIZE, BY INTRAVENOUS INJECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL CATTLE HEALTH MARKET SIZE, BY TOPICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 187. GLOBAL CATTLE HEALTH MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL CATTLE HEALTH MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL CATTLE HEALTH MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 190. GLOBAL CATTLE HEALTH MARKET SIZE, BY POUR-ONS & SPOT-ONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL CATTLE HEALTH MARKET SIZE, BY POUR-ONS & SPOT-ONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL CATTLE HEALTH MARKET SIZE, BY POUR-ONS & SPOT-ONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. GLOBAL CATTLE HEALTH MARKET SIZE, BY SPRAYS & DIPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL CATTLE HEALTH MARKET SIZE, BY SPRAYS & DIPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL CATTLE HEALTH MARKET SIZE, BY SPRAYS & DIPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. GLOBAL CATTLE HEALTH MARKET SIZE, BY OINTMENTS & CREAMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL CATTLE HEALTH MARKET SIZE, BY OINTMENTS & CREAMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 198. GLOBAL CATTLE HEALTH MARKET SIZE, BY OINTMENTS & CREAMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. GLOBAL CATTLE HEALTH MARKET SIZE, BY INTRAMAMMARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 200. GLOBAL CATTLE HEALTH MARKET SIZE, BY INTRAMAMMARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 201. GLOBAL CATTLE HEALTH MARKET SIZE, BY INTRAMAMMARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. GLOBAL CATTLE HEALTH MARKET SIZE, BY INTRAMAMMARY, 2018-2032 (USD MILLION)
  • TABLE 203. GLOBAL CATTLE HEALTH MARKET SIZE, BY LACTATING COW INTRAMAMMARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 204. GLOBAL CATTLE HEALTH MARKET SIZE, BY LACTATING COW INTRAMAMMARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 205. GLOBAL CATTLE HEALTH MARKET SIZE, BY LACTATING COW INTRAMAMMARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 206. GLOBAL CATTLE HEALTH MARKET SIZE, BY DRY COW INTRAMAMMARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 207. GLOBAL CATTLE HEALTH MARKET SIZE, BY DRY COW INTRAMAMMARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 208. GLOBAL CATTLE HEALTH MARKET SIZE, BY DRY COW INTRAMAMMARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 209. GLOBAL CATTLE HEALTH MARKET SIZE, BY INTRANASAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 210. GLOBAL CATTLE HEALTH MARKET SIZE, BY INTRANASAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 211. GLOBAL CATTLE HEALTH MARKET SIZE, BY INTRANASAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 212. GLOBAL CATTLE HEALTH MARKET SIZE, BY IMPLANTABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 213. GLOBAL CATTLE HEALTH MARKET SIZE, BY IMPLANTABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 214. GLOBAL CATTLE HEALTH MARKET SIZE, BY IMPLANTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 215. GLOBAL CATTLE HEALTH MARKET SIZE, BY IMPLANTABLE, 2018-2032 (USD MILLION)
  • TABLE 216. GLOBAL CATTLE HEALTH MARKET SIZE, BY GROWTH & HORMONAL IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 217. GLOBAL CATTLE HEALTH MARKET SIZE, BY GROWTH & HORMONAL IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 218. GLOBAL CATTLE HEALTH MARKET SIZE, BY GROWTH & HORMONAL IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 219. GLOBAL CATTLE HEALTH MARKET SIZE, BY LONG-ACTING DRUG IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 220. GLOBAL CATTLE HEALTH MARKET SIZE, BY LONG-ACTING DRUG IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 221. GLOBAL CATTLE HEALTH MARKET SIZE, BY LONG-ACTING DRUG IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 222. GLOBAL CATTLE HEALTH MARKET SIZE, BY FEED-BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 223. GLOBAL CATTLE HEALTH MARKET SIZE, BY FEED-BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 224. GLOBAL CATTLE HEALTH MARKET SIZE, BY FEED-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. GLOBAL CATTLE HEALTH MARKET SIZE, BY WATER-BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 226. GLOBAL CATTLE HEALTH MARKET SIZE, BY WATER-BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 227. GLOBAL CATTLE HEALTH MARKET SIZE, BY WATER-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 228. GLOBAL CATTLE HEALTH MARKET SIZE, BY DISEASE AREA, 2018-2032 (USD MILLION)
  • TABLE 229. GLOBAL CATTLE HEALTH MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 230. GLOBAL CATTLE HEALTH MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 231. GLOBAL CATTLE HEALTH MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. GLOBAL CATTLE HEALTH MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 233. GLOBAL CATTLE HEALTH MARKET SIZE, BY BACTERIAL INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 234. GLOBAL CATTLE HEALTH MARKET SIZE, BY BACTERIAL INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 235. GLOBAL CATTLE HEALTH MARKET SIZE, BY BACTERIAL INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 236. GLOBAL CATTLE HEALTH MARKET SIZE, BY VIRAL INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 237. GLOBAL CATTLE HEALTH MARKET SIZE, BY VIRAL INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 238. GLOBAL CATTLE HEALTH MARKET SIZE, BY VIRAL INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 239. GLOBAL CATTLE HEALTH MARKET SIZE, BY FUNGAL INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 240. GLOBAL CATTLE HEALTH MARKET SIZE, BY FUNGAL INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 241. GLOBAL CATTLE HEALTH MARKET SIZE, BY FUNGAL INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 242. GLOBAL CATTLE HEALTH MARKET SIZE, BY MIXED & OPPORTUNISTIC INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 243. GLOBAL CATTLE HEALTH MARKET SIZE, BY MIXED & OPPORTUNISTIC INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 244. GLOBAL CATTLE HEALTH MARKET SIZE, BY MIXED & OPPORTUNISTIC INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 245. GLOBAL CATTLE HEALTH MARKET SIZE, BY PARASITIC DISEASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 246. GLOBAL CATTLE HEALTH MARKET SIZE, BY PARASITIC DISEASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 247. GLOBAL CATTLE HEALTH MARKET SIZE, BY PARASITIC DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 248. GLOBAL CATTLE HEALTH MARKET SIZE, BY PARASITIC DISEASES, 2018-2032 (USD MILLION)
  • TABLE 249. GLOBAL CATTLE HEALTH MARKET SIZE, BY INTERNAL PARASITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 250. GLOBAL CATTLE HEALTH MARKET SIZE, BY INTERNAL PARASITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 251. GLOBAL CATTLE HEALTH MARKET SIZE, BY INTERNAL PARASITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 252. GLOBAL CATTLE HEALTH MARKET SIZE, BY EXTERNAL PARASITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 253. GLOBAL CATTLE HEALTH MARKET SIZE, BY EXTERNAL PARASITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 254. GLOBAL CATTLE HEALTH MARKET SIZE, BY EXTERNAL PARASITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 255. GLOBAL CATTLE HEALTH MARKET SIZE, BY PROTOZOAL INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 256. GLOBAL CATTLE HEALTH MARKET SIZE, BY PROTOZOAL INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 257. GLOBAL CATTLE HEALTH MARKET SIZE, BY PROTOZOAL INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 258. GLOBAL CATTLE HEALTH MARKET SIZE, BY MASTITIS & UDDER HEALTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 259. GLOBAL CATTLE HEALTH MARKET SIZE, BY MASTITIS & UDDER HEALTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 260. GLOBAL CATTLE HEALTH MARKET SIZE, BY MASTITIS & UDDER HEALTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 261. GLOBAL CATTLE HEALTH MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 262. GLOBAL CATTLE HEALTH MARKET SIZE, BY RESPIRATORY DISEASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 263. GLOBAL CATTLE HEALTH MARKET SIZE, BY RESPIRATORY DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 264. GLOBAL CATTLE HEALTH MARKET SIZE, BY RESPIRATORY DISEASES, 2018-2032 (USD MILLION)
  • TABLE 265. GLOBAL CATTLE HEALTH MARKET SIZE, BY UPPER RESPIRATORY DISEASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 266. GLOBAL CATTLE HEALTH MARKET SIZE, BY UPPER RESPIRATORY DISEASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 267. GLOBAL CATTLE HEALTH MARKET SIZE, BY UPPER RESPIRATORY DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 268. GLOBAL CATTLE HEALTH MARKET SIZE, BY LOWER RESPIRATORY DISEASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 269. GLOBAL CATTLE HEALTH MARKET SIZE, BY LOWER RESPIRATORY DISEASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 270. GLOBAL CATTLE HEALTH MARKET SIZE, BY LOWER RESPIRATORY DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 271. GLOBAL CATTLE HEALTH MARKET SIZE, BY COMPLEX RESPIRATORY SYNDROMES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 272. GLOBAL CATTLE HEALTH MARKET SIZE, BY COMPLEX RESPIRATORY SYNDROMES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 273. GLOBAL CATTLE HEALTH MARKET SIZE, BY COMPLEX RESPIRATORY SYNDROMES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 274. GLOBAL CATTLE HEALTH MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 275. GLOBAL CATTLE HEALTH MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 276. GLOBAL CATTLE HEALTH MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 277. GLOBAL CATTLE HEALTH MARKET SIZE, BY GASTROINTESTINAL DISEASES, 2018-2032 (USD MILLION)
  • TABLE 278. GLOBAL CATTLE HEALTH MARKET SIZE, BY DIARRHEAL DISEASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 279. GLOBAL CATTLE HEALTH MARKET SIZE, BY DIARRHEAL DISEASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 280. GLOBAL CATTLE HEALTH MARKET SIZE, BY DIARRHEAL DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 281. GLOBAL CATTLE HEALTH MARKET SIZE, BY BLOAT & ACIDOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 282. GLOBAL CATTLE HEALTH MARKET SIZE, BY BLOAT & ACIDOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 283. GLOBAL CATTLE HEALTH MARKET SIZE, BY BLOAT & ACIDOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 284. GLOBAL CATTLE HEALTH MARKET SIZE, BY METABOLIC & NUTRITIONAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 285. GLOBAL CATTLE HEALTH MARKET SIZE, BY METABOLIC & NUTRITIONAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 286. GLOBAL CATTLE HEALTH MARKET SIZE, BY METABOLIC & NUTRITIONAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 287. GLOBAL CATTLE HEALTH MARKET SIZE, BY METABOLIC & NUTRITIONAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 288. GLOBAL CATTLE HEALTH MARKET SIZE, BY ENERGY METABOLISM DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 289. GLOBAL CATTLE HEALTH MARKET SIZE, BY ENERGY METABOLISM DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 290. GLOBAL CATTLE HEALTH MARKET SIZE, BY ENERGY METABOLISM DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 291. GLOBAL CATTLE HEALTH MARKET SIZE, BY MINERAL IMBALANCES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 292. GLOBAL CATTLE HEALTH MARKET SIZE, BY MINERAL IMBALANCES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 293. GLOBAL CATTLE HEALTH MARKET SIZE, BY MINERAL IMBALANCES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 294. GLOBAL CATTLE HEALTH MARKET SIZE, BY VITAMIN DEFICIENCIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 295. GLOBAL CATTLE HEALTH MARKET SIZE, BY VITAMIN DEFICIENCIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 296. GLOBAL CATTLE HEALTH MARKET SIZE, BY VITAMIN DEFICIENCIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 297. GLOBAL CATTLE HEALTH MARKET SIZE, BY RUMEN FUNCTION DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 298. GLOBAL CATTLE HEALTH MARKET SIZE, BY RUMEN FUNCTION DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 299. GLOBAL CATTLE HEALTH MARKET SIZE, BY RUMEN FUNCTION DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 300. GLOBAL CATTLE HEALTH MARKET SIZE, BY REPRODUCTIVE & OBSTETRIC DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 301. GLOBAL CATTLE HEALTH MARKET SIZE, BY REPRODUCTIVE & OBSTETRIC DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 302. GLOBAL CATTLE HEALTH MARKET SIZE, BY REPRODUCTIVE & OBSTETRIC DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 303. GLOBAL CATTLE HEALTH MARKET SIZE, BY REPRODUCTIVE & OBSTETRIC DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 304. GLOBAL CATTLE HEALTH MARKET SIZE, BY FERTILITY MANAGEMENT ISSUES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 305. GLOBAL CATTLE HEALTH MARKET SIZE, BY FERTILITY MANAGEMENT ISSUES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 306. GLOBAL CATTLE HEALTH MARKET SIZE, BY FERTILITY MANAGEMENT ISSUES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 307. GLOBAL CATTLE HEALTH MARKET SIZE, BY PERIPARTUM & POSTPARTUM DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 308. GLOBAL CATTLE HEALTH MARKET SIZE, BY PERIPARTUM & POSTPARTUM DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 309. GLOBAL CATTLE HEALTH MARKET SIZE, BY PERIPARTUM & POSTPARTUM DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 310. GLOBAL CATTLE HEALTH MARKET SIZE, BY VENEREAL DISEASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 311. GLOBAL CATTLE HEALTH MARKET SIZE, BY VENEREAL DISEASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 312. GLOBAL CATTLE HEALTH MARKET SIZE, BY VENEREAL DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 313. GLOBAL CATTLE HEALTH MARKET SIZE, BY LAMENESS & MUSCULOSKELETAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 314. GLOBAL CATTLE HEALTH MARKET SIZE, BY LAMENESS & MUSCULOSKELETAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 315. GLOBAL CATTLE HEALTH MARKET SIZE, BY LAM